Presentation at Bloom Burton & Co. Healthcare Investor Conference

DRI Healthcare to Host Second Quarter 2025 Earnings Call and Webcast on August 14, 2025

DRI Healthcare Comments on FDA Approval and our Increased Investment in KalVista Pharmaceuticals' Ekterly® (sebetrals...

DRI Healthcare Announces Closing of Internalization Transaction